BREAST CANCER: A STORY HALF TOLD PRESS KIT

story half told

Breast Cancer: A Story Half Told体育投注正规网址 is an initiative by Pfizer, which launched in 2014 in partnership with advocates, patients and healthcare professionals. The initiative aims to elevate public understanding of metastatic breast cancer, dispel misperceptions, combat stigma and expand the breast cancer conversation to be more inclusive of metastatic breast cancer.

News:

2016: Pfizer Awards More Than $1 Million in Metastatic Breast Cancer Research Funding Through Breast Cancer: A Story Half Told Initiative

2014: New Survey Finds Majority of Women with Breast Cancer Who Work Want to Do So Even While Undergoing Treatment

Patients Tell The Other Side Of The Story:

Beth Fairchild

Story Half Told shares the perspectives of people living with metastatic breast cancer as chronicled by prominent photographers. The people openly share the realities of the disease and the joys of their lives through this program. This photography-based initiative is featured on the @StoryHalfTold体育投注正规网址 Instagram account, as well as on and the program's Facebook account.

In 2018, Story Half Told expanded the metastatic breast cancer conversation with the launch of , a larger platform that encourages the broader metastatic breast cancer community to share experiences, tips, or words of inspiration.

HelpAge_300x170_V2Pflugerville, TX
meet_beth_220pxNew Bern, NC
meet_khadijah_220pxBrooklyn, NY
meet_carol_220pxOcala, FL
remembering_holley_220pxCedar Park, TX

In 2017, Story Half Told welcomed its first-ever male MBC patient, Michael Kovarik, to help shine a light on metastatic breast cancer and male breast cancer. In 2018, it is estimated that over 2.5K men will be diagnosed with breast cancer.

Story Half Told introduced Sheila McGlown, a 25-year veteran of the United States Air Force and MBC advocate in 2018. Sheila is excited to share her story and raise awareness for breast cancer within the African-American community, where women with breast cancer are, on average, 40% more likely to die of the disease than white women with breast cancer.2  

Most recently, Story Half Told brought hereditary breast cancer and the importance of genetic testing to the forefront with the story of , a patient with MBC and BRCA2 and CHEK2 mutations. People with breast cancer due to an inherited genetic mutation may face unique challenges, including access to genetic counseling, and the weight of the knowledge that family members may be at risk.

In 2017, Story Half Told welcomed its first-ever male MBC patient, Michael Kovarik, to help shine a light on metastatic breast cancer and male breast cancer. In 2018, it is estimated that over 2.5K men will be diagnosed with breast cancer.

Story Half Told introduced Sheila McGlown, a 25-year veteran of the United States Air Force and MBC advocate in 2018. Sheila is excited to share her story and raise awareness for breast cancer within the African-American community, where women with breast cancer are, on average, 40% more likely to die of the disease than white women with breast cancer.2体育投注正规网址  

Most recently, Story Half Told体育投注正规网址 brought hereditary breast cancer and the importance of genetic testing to the forefront with the story of , a patient with MBC and BRCA2 and CHEK2 mutations. People with breast cancer due to an inherited genetic mutation may face unique challenges, including access to genetic counseling, and the weight of the knowledge that family members may be at risk.

References:1. American Cancer Society. Key statistics for breast cancer in men. . Accessed January 30, 2018.
2. American Cancer Society. Breast cancer facts & figures 2017-2018. . Accessed January 19, 2018.

FOUNDATIONAL RESEARCH

Story-Half-Told_Section-header_620px

In 2014, zawajfun.commissioned three complementary studies to inspire change: an in-office study which revealed gaps in patient-physician dialogue; a workplace study, which examined the perspectives of working women with breast cancer, healthcare professionals and employers; as well as a general public survey which revealed gaps in understanding and awareness in metastatic breast cancer.

体育投注正规网址In 2018, Pfizer brought together a group of multidisciplinary experts and also conducted a survey of patients with breast cancer to identify the needs of people living with hereditary breast cancer, barriers to genetic testing and recommendations to address these challenges.

Story Half Told Materials

Story Half Told Overview

Statement of Need

Metastatic Breast Cancer Infographic

Shirley Mertz, JD, President, Metastatic Breast Cancer Network, on Expanding the Metastatic Breast Cancer Dialogue (Video)

Disparities in Breast Cancer Infographic

Hereditary Breast Cancer Resources

Statement of Need Genetic Testing Addendum

Understanding Hereditary Breast Cancer Infographic

Workplace Resources

Working Through Breast Cancer

The Employer and HCP Role in Supporting Working Women with Breast Cancer

Lillie Shockney, RN, on Supporting Workplace Conversations (Video)

Click below to explore the work being done by

OUR PARTNERS IN METASTATIC BREAST CANCER